Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma

S.H. Hutajulu, J. Kurnianda, I.B. Tan, J.M. Middeldorp

Research output: Contribution to journal › Article › Academic › peer-review

46 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	721-736
Journal	Therapeutics and Clinical Risk Management
Volume	10
DOIs	https://doi.org/10.2147/TCRM.S47434
Publication status	Published - 2014

Access to Document

@article{95f3e8a996eb42fba919964c62ce7a11,

title = "Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma",

author = "S.H. Hutajulu and J. Kurnianda and I.B. Tan and J.M. Middeldorp",

year = "2014",

doi = "https://doi.org/10.2147/TCRM.S47434",

language = "Undefined/Unknown",

volume = "10",

pages = "721--736",

journal = "Therapeutics and Clinical Risk Management",

issn = "1176-6336",

publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma

AU - Hutajulu, S.H.

AU - Kurnianda, J.

AU - Tan, I.B.

AU - Middeldorp, J.M.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.2147/TCRM.S47434

DO - https://doi.org/10.2147/TCRM.S47434

M3 - Article

SN - 1176-6336

VL - 10

SP - 721

EP - 736

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

ER -